Actual and perceived gender differences in virtual tumor board participation.

Discourse style Gender disparities Tumor board Virtual

Journal

Surgery open science
ISSN: 2589-8450
Titre abrégé: Surg Open Sci
Pays: United States
ID NLM: 101768812

Informations de publication

Date de publication:
Dec 2023
Historique:
received: 14 06 2023
accepted: 08 09 2023
medline: 25 9 2023
pubmed: 25 9 2023
entrez: 25 9 2023
Statut: epublish

Résumé

Participant characteristics are known to affect group discourse and discussion outcomes. In medicine, many decisions are made by group consensus, therefore an understanding of these factors is highly relevant. We aimed to measure the effects of participant characteristics on tumor board discussions. We performed a prospective, multi-institution, quantitative study of multi-disciplinary virtual tumor board meetings. Participant characteristics included age, gender, and clinical discipline. Outcomes of interest were speech events, duration, and discourse style. Participant impressions was assessed by a post-hoc survey. A total of 361 cases were discussed across 32 virtual meetings. Of the 283 attendees, 66.4 % were women, and all moderators were men. Women comprised 43 % of the 54 speakers, thus speaking less than male attendees ( Women physicians were underrepresented in tumor boards as moderators, speakers, and attendings of record. Women physicians commented less on men physicians' patients. Women felt less impactful than their men counterparts, despite having the same duration and style of speech. Prompted participation, moderator feedback, talking points, and limiting the number of cases can be used to balance representation in discussions.

Identifiants

pubmed: 37744313
doi: 10.1016/j.sopen.2023.09.004
pii: S2589-8450(23)00069-6
pmc: PMC10517280
doi:

Types de publication

Journal Article

Langues

eng

Pagination

28-32

Subventions

Organisme : NCATS NIH HHS
ID : UL1 TR004419
Pays : United States

Informations de copyright

© 2023 The Authors. Published by Elsevier Inc.

Déclaration de conflit d'intérêts

We know of no conflict of interested associated with our publication.

Références

Pulm Ther. 2021 Dec;7(2):295-308
pubmed: 34089169
Cureus. 2019 Dec 3;11(12):e6285
pubmed: 31911877
BMJ. 2017 Oct 10;359:j4366
pubmed: 29018008
JAMA Netw Open. 2022 Jan 4;5(1):e2143139
pubmed: 35019985
BMC Musculoskelet Disord. 2021 Jan 5;22(1):18
pubmed: 33402136
World J Urol. 2018 Jul;36(7):1031-1038
pubmed: 29502300
J Microbiol Biol Educ. 2022 Mar 28;23(1):
pubmed: 35496681
J Surg Oncol. 2022 Mar;125(4):570-576
pubmed: 34994401
Proc Natl Acad Sci U S A. 2018 Aug 21;115(34):8569-8574
pubmed: 30082406
Asia Pac J Clin Oncol. 2020 Feb;16(1):45-55
pubmed: 31721458
J Oncol Pract. 2016 Nov;12(11):1000-1011
pubmed: 27756800
CBE Life Sci Educ. 2020 Sep;19(3):ar30
pubmed: 32644001
JAMA Intern Med. 2017 Feb 1;177(2):206-213
pubmed: 27992617

Auteurs

Yael Berger (Y)

Beilinson Medical Center, 39 Jabotinski Street Petah-Tikva, Israel.

Alison Buseck (A)

Division of Surgical Oncology, The Icahn School of Medicine at Mount Sinai, 425 W 59th Street 7th Floor, New York, NY, USA.

Sayed Imtiaz (S)

Division of Surgical Oncology, The Icahn School of Medicine at Mount Sinai, 425 W 59th Street 7th Floor, New York, NY, USA.

Callie Horn (C)

Division of Surgical Oncology, The Icahn School of Medicine at Mount Sinai, 425 W 59th Street 7th Floor, New York, NY, USA.

Nazanin Khajoueinejad (N)

Division of Surgical Oncology, The Icahn School of Medicine at Mount Sinai, 425 W 59th Street 7th Floor, New York, NY, USA.

Rebekah Macfie (R)

Division of Surgical Oncology, The Icahn School of Medicine at Mount Sinai, 425 W 59th Street 7th Floor, New York, NY, USA.

Noah Cohen (N)

Division of Surgical Oncology, The Icahn School of Medicine at Mount Sinai, 425 W 59th Street 7th Floor, New York, NY, USA.

Umut Sarpel (U)

Division of Surgical Oncology, The Icahn School of Medicine at Mount Sinai, 425 W 59th Street 7th Floor, New York, NY, USA.

Classifications MeSH